Clinical Trial Details

EORTC-1419-BTG

Back to Clinical Trials Database

Molecular genetic, host-derived and clinical determinants of long-term survival in glioblastoma

Study documentation

Trial Status Recruiting
Dates Date of activation: 29-Jun-2015
Data management at EORTC Yes
Design Cross-sectional
Not randomized / N.A.
Targeted Sample size EORTC Groups: 230 - All Groups: 400
Treatment None
Study Staff Michael Weller (Study Coordinator) , UniversitaetsSpital Zurich - Neurology Clinic, Zurich
Thierry Gorlia (Statistician) , EORTC Headquarters, Brussels
Sylvie Ledroit (Clinical Operations Assistant) , EORTC Headquarters, Brussels
Giulia Leonetti (Project Manager) , EORTC Headquarters, Brussels
Hafida Lmalem (Imaging Officer) , EORTC Headquarters, Brussels
Sandrine Marreaud (Clinical Research Physician) , EORTC Headquarters, Brussels
Arianne Marrez (Junior Clinical Operations Manager) , EORTC Headquarters, Brussels
Sara Meloen (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Sara Nicolas (Regulatory Affairs Manager) , EORTC Headquarters, Brussels
Maarten Spruyt (Data Manager) , EORTC Headquarters, Brussels
Jelle Stans (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels
Laurien Vancleef (Clinical Operations Manager) , EORTC Headquarters, Brussels
Maureen Vanlancker (Clinical Research Physician) , EORTC Headquarters, Brussels
Tina Verschuere (Senior Clinical Operations Manager) , EORTC Headquarters, Brussels
Xiao Mang Zhou (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels
Type of cancer Brain
Participating groups EORTC Brain Tumor Group
Brain Tumor Funders' Collaborative
Recruiting centers Amsterdam UMC - locatie VUMC (Amsterdam, Netherlands)
Assistance Publique - Hopitaux de Paris - Hopital Avicenne (Bobigny, France)
Assistance Publique - Hopitaux de Paris - La Pitie Salpetriere (Paris, France)
Assitance Publique - Hopitaux de Paris - Hopital Saint-Louis (Paris, France)
Azienda Ospedaliera Città della Salute e della Scienza di Torino - Ospedale San Giovanni - Dipartimento Neuroscienze (Torino, Italy)
CHRU de Lille (Lille, France)
CHU Amiens - Hopital Sud (Salouel, France)
CHU Lyon - Hopital neurologique Pierre Wertheimer (Bron, France)
CHU de Nice - Hopital Pasteur (Nice, France)
Centre Hospitalier Universitaire Vaudois - Lausanne (Lausanne, Switzerland)
Dana-Farber Cancer Institute & Harvard Medical School (Boston, United States of America)
Erasmus MC (Rotterdam, Netherlands)
Hopital Universitaires Erasme (Brussels, Belgium)
Hopital de La Timone (APHM) (Marseille, France)
Hygeia Hospital (Athens, Greece)
IRCCS - Istituto Oncologico Veneto (Padova, Italy)
Institut du Cancer de Montpellier (Montpellier, France)
Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern (Muenchen, Germany)
Prince Of Wales Hospital (Randwick - Sydney, Australia)
UniversitaetsKlinikum Heidelberg - Head Hospital (Heidelberg, Germany)
UniversitaetsSpital Zurich (Zurich, Switzerland)
Universitaetsklinikum - Essen (Essen, Germany)
Universitaetsklinikum Bonn (Bonn, Germany)
Universitaetsklinikum Carl Gustav Carus (Dresden, Germany)
Universitaetsklinikum Freiburg - Klinik fuer Neurochirurgie (Freiburg, Germany)
Universitaetsklinikum Regensburg (Regensburg, Germany)
Universitaetsklinikum Wien - AKH uniklinieken (Vienna, Austria)
Universitaetsklinikum Wien - AKH uniklinieken (Vienna, Austria)
Centers to be activated Haaglanden MC - locatie Antoniushove ( Leidschendam, Netherlands)
Penn State College of Medicine, Hershey Medical Center-Penn State Neuroscience Institute (Hershey, United States of America)
Technische Universitaet Muenchen - Klinikum Rechts Der Isar (Muenchen, Germany)
Universitaetsklinikum Tuebingen- Crona Kliniken (Tuebingen, Germany)
University Hospital Frankfurt -Senckenberg Institute of Neurooncology (Frankfurt am Main, Germany)
University of California (San Francisco, United States of America)
Protocol summary http://clinicaltrials.gov/ct/show/
NCT number